What AI says about AAVantgarde Bio

AAVantgarde is a biotechnology company pioneering next-generation therapies for inherited retinal disorders caused by large gene mutations, specifically Stargardt disease and Usher 1B syndrome. The company's technology enables the delivery of large genes like ABCA4 to address the genetic root cause of these conditions.